2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Wednesday, June 7, 2017

1:15pm-2:45pm: Differential peculiarities of cognitive disorders in Parkinson’s disease dementia and Vascular dementia

V. Mykhaylov, I. Zdesenko (Kharkiv, Ukraine)

Parkinson's Disease: Cognition · Exhibit Hall C

1:15pm-2:45pm: Difficulties in executing the MDS recommendations in the brazilian population

E. Carreira, E. CARREIRA, A. PRADO, N. BRAZ, F. TAVARES, N. ROCHA, L. DE SOUZA, F. CARDOSO, A. TEIXEIRA (Belo Horizonte, Brazil)

Cognitive Disorders · Exhibit Hall C

1:15pm-2:45pm: Diffusion Weighted Magnetic Resonance Imaging in Child Cerebral Palsy with Symptomatic Epilepsy

k. aminov (tashkent, Uzbekistan)

Neuroimaging (Non-PD) · Exhibit Hall C

1:15pm-2:45pm: Diplopia: An Interesting Complication of Dropped Head Syndrome

W. Deeb, I. Malaty (Gainesville, FL, USA)

Phenomenology and Clinical Assessment Of Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Distinguishing Subclinical Postural Instability in Early-stage Parkinson disease and postural instability of normal elderly using Sensory Organization Test and Limit of Stability

S.-K. Lee, J.-H. Park (Bucheon, Republic of Korea)

Phenomenology and Clinical Assessment Of Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Do Acetylcholinesterase Inhibitors (AChEI) delay institutionalisation in Parkinson’s and Lewy Body Disease?

L. Brown, B. Mohamed, E. Thomas (Cardiff, United Kingdom)

Parkinson's Disease: Cognition · Exhibit Hall C

1:15pm-2:45pm: Does levodopa-carbidopa intestinal gel in Parkinson’s disease patients increase the risk on polyneuropathy?

H. Moes, M. Drent, T. Laar (Groningen, Netherlands)

Neuropharmacology · Exhibit Hall C

1:15pm-2:45pm: Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis

J. Hinkle, K. Perepezko, C. Bakker, T. Dawson, V. Johnson, Z. Mari, C. Marvel, K. Mills, A. Pantelyat, O. Pletnikova, L. Rosenthal, M. Shepard, D. Stevens, J. Troncoso, J. Wang, G. Pontone (Baltimore, MD, USA)

Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C

1:15pm-2:45pm: Domain-specific impact of cerebral white matter hyperintensities on Parkinson’s disease cognitive functioning

P. Linortner, S. Chernavsky, T. Hendershott, K. Poston (Palo Alto, CA, USA)

Parkinson's Disease: Cognition · Exhibit Hall C

1:15pm-2:45pm: Dopamine agonist therapy mediates relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease.

T. Turner, J. Renfroe, V. Hinson (Charleston, SC, USA)

Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C